Beacon Cancer Care — Coeur d'Alene, Idaho

Beacon Cancer Care is a clinical research site located in Coeur d'Alene, Idaho, United States 83814.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Beacon Cancer Care has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Solid Tumor, Unresectable or Metastatic Melanoma, Soft Tissue Sarcoma.

Sponsors: CytomX Therapeutics, Eli Lilly and Company, Oncopeptides AB.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beacon Cancer Care?

Beacon Cancer Care has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beacon Cancer Care conducted?

Beacon Cancer Care has 4 clinical trials on record, with 1 currently active. Their work covers Solid Tumor, Unresectable or Metastatic Melanoma, Soft Tissue Sarcoma.

Is Beacon Cancer Care accredited by Crixeo Health?

Beacon Cancer Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beacon Cancer Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.